Scientific Sessions 2025  /  Approved and Novel Therapies for the Management of Obstructive and Nonobstructive HCM  /  Treatment of nonobstructive HCM: Where are we and where do we go?
Logo

American Heart Association

  40
  0

Final ID:

Treatment of nonobstructive HCM: Where are we and where do we go?

  • Owens, Anjali  ( University of Pennsylvania , Wallingford , Pennsylvania , United States )
    • Author Disclosures:
    Anjali Owens: DO have relevant financial relationships ; Consultant:Alexion:Active (exists now) ; Consultant:Stealth:Active (exists now) ; Consultant:Corvista:Active (exists now) ; Consultant:Tenaya:Active (exists now) ; Consultant:Lexeo:Active (exists now) ; Consultant:Imbria:Active (exists now) ; Consultant:Edgewise:Active (exists now) ; Consultant:Cytokinetics:Active (exists now) ; Consultant:Avidity:Active (exists now) ; Consultant:BMS:Active (exists now) ; Consultant:Biomarin:Active (exists now) ; Consultant:Bayer:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Approved and Novel Therapies for the Management of Obstructive and Nonobstructive HCM

Friday, 11/07/2025 , 12:45PM - 02:30PM

Cardiovascular Seminar

More abstracts on this topic:
CMIs in Obstructive HCM: Exploring Sequoia trees with Valor while enjoying Maple syrup

Saberi Sara

Invasive Therapies for Obstructive HCM: A shave, a tuck or a squirt?

Smedira Nicholas

More abstracts from these authors:
Opening Remarks

Owens Anjali

Panelist

Chatfield Kathryn, Owens Anjali

You have to be authorized to contact abstract author. Please, Login
Not Available